648 related articles for article (PubMed ID: 28440732)
1. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues.
Qiu D; Chen J; Liu J; Luo Z; Jiang W; Huang J; Qiu Z; Yue W; Wu L
Exp Biol Med (Maywood); 2017 May; 242(9):939-944. PubMed ID: 28440732
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
Song Y; Pan W; Fan Z; Du P; Qi Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
[TBL] [Abstract][Full Text] [Related]
4. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis.
Qiu Z; Zhou J; Zhang C; Cheng Y; Hu J; Zheng G
Braz J Med Biol Res; 2018; 51(7):e7220. PubMed ID: 29742265
[TBL] [Abstract][Full Text] [Related]
6. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
7. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
Shiota G; Oyama K; Udagawa A; Nomi T; Tanaka K; Tsutsumi A; Noguchi N; Okano J; Kishimoto Y; Kanbe T; Kishimoto H; Kawasaki H
Hepatogastroenterology; 2009; 56(94-95):1516-20. PubMed ID: 19950820
[TBL] [Abstract][Full Text] [Related]
8. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
[TBL] [Abstract][Full Text] [Related]
10. Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).
Guan R; Yap I; Wong L; Tan LH; Oon CJ; Wee A
Ann Acad Med Singap; 1989 Jan; 18(1):8-11. PubMed ID: 2540692
[TBL] [Abstract][Full Text] [Related]
11. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
14. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
16. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection and replication in a new cell culture system established by fusing HepG2 cells with primary human hepatocytes.
Sai LT; Yao YY; Guan YY; Shao LH; Ma RP; Ma LX
J Microbiol Immunol Infect; 2016 Aug; 49(4):471-6. PubMed ID: 25442856
[TBL] [Abstract][Full Text] [Related]
18. [Study on the correlation among quantification of HBV-DNA and HBeAg, anti-HBe in hepatitis B carriers].
Dou YL; Cheng XQ; Li YZ; Han JH; Ni AP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):709-11. PubMed ID: 17172114
[TBL] [Abstract][Full Text] [Related]
19. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
[TBL] [Abstract][Full Text] [Related]
20. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
